• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

建立和验证一种同时测定猪全血和肺组织中西罗莫司的 LC-MS/MS 生物分析方法及其在冠脉支架中应用的药代动力学研究

Development and Validation of a Bioanalytical LC-MS/MS Method for Simultaneous Determination of Sirolimus in Porcine Whole Blood and Lung Tissue and Pharmacokinetic Application with Coronary Stents.

机构信息

College of Pharmacy, Gachon University, Incheon 21936, Korea.

Department of New Drug Development, Inha University College of Medicine, Incheon 22212, Korea.

出版信息

Molecules. 2021 Jan 15;26(2):425. doi: 10.3390/molecules26020425.

DOI:10.3390/molecules26020425
PMID:33467464
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7829871/
Abstract

Sirolimus is a hydrophobic macrolide compound that has been used for long-term immunosuppressive therapy, prevention of restenosis, and treatment of lymphangioleiomyomatosis. In this study, a simple and sensitive liquid chromatography-tandem mass spectrometry (LC-MS/MS) was developed and validated for the simultaneous determination of sirolimus in both porcine whole blood and lung tissue. Blood and lung tissue homogenates were deproteinized with acetonitrile and injected into the LC-MS/MS system for analysis using the positive electrospray ionization mode. The drug was separated on a C18 reversed phase column with a gradient mobile phase (ammonium formate buffer (5 mM) with 0.1% formic acid and acetonitrile) at 0.2 mL/min. The selected reaction monitoring transitions of / 931.5 → 864.4 and 809.5 → 756.5 were applied for sirolimus and ascomycin (the internal standard, IS), respectively. The method was selective and linear over a concentration range of 0.5-50 ng/mL. The method was validated for sensitivity, accuracy, precision, extraction recovery, matrix effect, and stability in porcine whole blood and lung tissue homogenates, and all values were within acceptable ranges. The method was applied to a pharmacokinetic study to quantitate sirolimus levels in porcine blood and its distribution in lung tissue following the application of stents in the porcine coronary arteries. It enabled the quantification of sirolimus concentration until 2 and 14 days in blood and in lung tissue, respectively. This method would be appropriate for both routine porcine pharmacokinetic and bio-distribution studies of sirolimus formulations.

摘要

西罗莫司是一种疏水性大环内酯化合物,已被用于长期免疫抑制治疗、预防再狭窄和治疗淋巴管平滑肌瘤病。在这项研究中,开发并验证了一种简单而灵敏的液相色谱-串联质谱(LC-MS/MS)方法,用于同时测定猪全血和肺组织中的西罗莫司。用乙腈对血液和肺组织匀浆进行蛋白沉淀,然后注入 LC-MS/MS 系统,采用正电喷雾电离模式进行分析。药物在 C18 反相柱上以梯度流动相(5 mM 甲酸铵缓冲液含 0.1%甲酸和乙腈)在 0.2 mL/min 下进行分离。选择反应监测转换 / 931.5 → 864.4 和 809.5 → 756.5 分别用于西罗莫司和依维莫司(内标,IS)。该方法在 0.5-50 ng/mL 的浓度范围内具有选择性和线性。该方法已在猪全血和肺组织匀浆中进行了灵敏度、准确性、精密度、提取回收率、基质效应和稳定性验证,所有值均在可接受范围内。该方法应用于药代动力学研究,定量分析猪冠状动脉支架植入后猪血液中西罗莫司的浓度及其在肺组织中的分布。该方法能够定量检测血液中西罗莫司浓度直至 2 天和 14 天,肺组织中浓度直至 14 天。该方法适用于常规猪药代动力学和西罗莫司制剂的生物分布研究。

相似文献

1
Development and Validation of a Bioanalytical LC-MS/MS Method for Simultaneous Determination of Sirolimus in Porcine Whole Blood and Lung Tissue and Pharmacokinetic Application with Coronary Stents.建立和验证一种同时测定猪全血和肺组织中西罗莫司的 LC-MS/MS 生物分析方法及其在冠脉支架中应用的药代动力学研究
Molecules. 2021 Jan 15;26(2):425. doi: 10.3390/molecules26020425.
2
Pharmacokinetic study of sirolimus ophthalmic formulations by consecutive sampling and liquid chromatography-tandem mass spectrometry.西罗莫司眼用制剂的药代动力学研究:连续采样和液相色谱-串联质谱法。
J Pharm Biomed Anal. 2019 Feb 5;164:337-344. doi: 10.1016/j.jpba.2018.10.051. Epub 2018 Oct 31.
3
Quantitative determination of sirolimus in dog blood using liquid chromatography-tandem mass spectrometry, and its applications to pharmacokinetic studies.采用液相色谱-串联质谱法定量测定犬血中西罗莫司及其在药代动力学研究中的应用。
J Pharm Biomed Anal. 2010 Dec 1;53(4):1042-7. doi: 10.1016/j.jpba.2010.06.030. Epub 2010 Jul 7.
4
Sensitive quantification of sirolimus and everolimus by LC-MS/MS with online sample cleanup.LC-MS/MS 在线样品净化法灵敏定量检测西罗莫司和依维莫司
J Chromatogr B Analyt Technol Biomed Life Sci. 2010 Apr 15;878(13-14):1007-12. doi: 10.1016/j.jchromb.2010.02.029. Epub 2010 Mar 6.
5
Liquid chromatography-tandem mass spectrometry method for determination of Sirolimus coated drug eluting nano porous carbon stents.液相色谱-串联质谱法测定西罗莫司涂层药物洗脱纳米多孔碳支架
Biomed Chromatogr. 2010 Mar;24(3):329-34. doi: 10.1002/bmc.1295.
6
Development of a precise quantitative method for monitoring sirolimus in whole blood using LC/ESI-MS/MS.开发一种使用液相色谱/电喷雾串联质谱法监测全血中西罗莫司的精确定量方法。
Biomed Chromatogr. 2020 Aug;34(8):e4853. doi: 10.1002/bmc.4853. Epub 2020 May 22.
7
Simultaneous quantitation of hydroxychloroquine and its metabolites in mouse blood and tissues using LC-ESI-MS/MS: An application for pharmacokinetic studies.使用液相色谱-电喷雾串联质谱法同时定量小鼠血液和组织中的羟氯喹及其代谢物:在药代动力学研究中的应用。
J Chromatogr B Analyt Technol Biomed Life Sci. 2018 Jan 1;1072:320-327. doi: 10.1016/j.jchromb.2017.11.026. Epub 2017 Nov 23.
8
Development and validation of LC-MS/MS method for simultaneous determination of sofosbuvir and daclatasvir in human Plasma: Application to pharmacokinetic study.用于同时测定人血浆中索磷布韦和达卡他韦的液相色谱-串联质谱法的建立与验证:在药代动力学研究中的应用
Biomed Chromatogr. 2018 Jun;32(6):e4186. doi: 10.1002/bmc.4186. Epub 2018 Jan 29.
9
High-throughput LC-MS/MS method for monitoring sirolimus and everolimus in the routine clinical laboratory.用于常规临床实验室中监测西罗莫司和依维莫司的高通量 LC-MS/MS 方法。
Clin Chem Lab Med. 2011 Jul;49(7):1151-8. doi: 10.1515/CCLM.2011.192. Epub 2011 May 17.
10
Development and Validation of High-Throughput Bioanalytical Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) Method for the Quantification of Newly Synthesized Antitumor Carbonic Anhydrase Inhibitors in Human Plasma.开发和验证高通量生物分析液相色谱-串联质谱(LC-MS/MS)方法,用于定量人血浆中新合成的抗肿瘤碳酸酐酶抑制剂。
Molecules. 2020 Dec 6;25(23):5753. doi: 10.3390/molecules25235753.

引用本文的文献

1
Preparation and in vivo and ex vivo studies of sirolimus nano-in-situ gel ophthalmic formulation.西罗莫司纳米原位凝胶眼用制剂的制备及体内和体外研究
J Nanobiotechnology. 2024 Jul 16;22(1):417. doi: 10.1186/s12951-024-02668-1.
2
Lung microdialysis and PK/PD integration of cefquinome against in a porcine experimental lung infection model.在猪实验性肺部感染模型中进行的肺微透析及头孢喹肟的药代动力学/药效学整合研究
Front Vet Sci. 2024 Mar 26;11:1390336. doi: 10.3389/fvets.2024.1390336. eCollection 2024.
3
Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementation.

本文引用的文献

1
Determination of KD025 (SLx-2119), a Selective ROCK2 Inhibitor, in Rat Plasma by High-Performance Liquid Chromatography-Tandem Mass Spectrometry and its Pharmacokinetic Application.采用高效液相色谱-串联质谱法测定选择性 ROCK2 抑制剂 KD025(SLx-2119)在大鼠血浆中的浓度及其药代动力学应用。
Molecules. 2020 Mar 17;25(6):1369. doi: 10.3390/molecules25061369.
2
The Use of Sirolimus for Treatment of Orbital Lymphatic Malformations: A Systematic Review.西罗莫司治疗眼眶淋巴管畸形的应用:系统评价。
Ophthalmic Plast Reconstr Surg. 2020 May/Jun;36(3):215-221. doi: 10.1097/IOP.0000000000001518.
3
A phase I/II study of pemetrexed with sirolimus in advanced, previously treated non-small cell lung cancer.
推进纳米技术以改善癌症靶向治疗:克服其临床实施中的障碍。
Mol Cancer. 2023 Oct 9;22(1):169. doi: 10.1186/s12943-023-01865-0.
4
Formulation and Evaluation of a Self-Microemulsifying Drug Delivery System of Raloxifene with Improved Solubility and Oral Bioavailability.雷洛昔芬自微乳化药物传递系统的制剂研发与评价:提高溶解度与口服生物利用度
Pharmaceutics. 2023 Aug 2;15(8):2073. doi: 10.3390/pharmaceutics15082073.
5
Monitoring of sirolimus in the whole blood samples from pediatric patients with lymphatic anomalies.对患有淋巴管异常的儿科患者全血样本中的西罗莫司进行监测。
Open Med (Wars). 2023 Mar 2;18(1):20230652. doi: 10.1515/med-2023-0652. eCollection 2023.
6
Simultaneous Determination of Moxifloxacin Hydrochloride and Dexamethasone Sodium Phosphate in Rabbit Ocular Tissues and Plasma by LC-MS/MS: Application for Pharmacokinetics Studies.LC-MS/MS 法同时测定兔眼组织和血浆中盐酸莫西沙星和地塞米松磷酸钠的浓度:用于药代动力学研究。
Molecules. 2022 Nov 16;27(22):7934. doi: 10.3390/molecules27227934.
7
Comparison of LC-MS/MS and EMIT methods for the precise determination of blood sirolimus in children with vascular anomalies.液相色谱-串联质谱法(LC-MS/MS)与酶放大免疫测定技术(EMIT)用于精确测定血管异常患儿血液中西罗莫司的比较
Front Pharmacol. 2022 Sep 6;13:925018. doi: 10.3389/fphar.2022.925018. eCollection 2022.
8
Development of an LC-MS/MS Method for ARV-110, a PROTAC Molecule, and Applications to Pharmacokinetic Studies.建立一种用于 ARV-110(一种 PROTAC 分子)的 LC-MS/MS 方法及其在药代动力学研究中的应用。
Molecules. 2022 Mar 18;27(6):1977. doi: 10.3390/molecules27061977.
9
Effects of 1α,25-dihydroxyvitamin D on the pharmacokinetics and biodistribution of ergothioneine, an endogenous organic cation/carnitine transporter 1 substrate, in rats.1α,25-二羟基维生素D对大鼠体内麦角硫因(一种内源性有机阳离子/肉碱转运体1底物)的药代动力学及生物分布的影响。
J Pharm Investig. 2022;52(3):341-351. doi: 10.1007/s40005-022-00563-1. Epub 2022 Mar 10.
10
TNBC: Potential Targeting of Multiple Receptors for a Therapeutic Breakthrough, Nanomedicine, and Immunotherapy.三阴性乳腺癌:针对多种受体实现治疗突破、纳米医学及免疫疗法的潜在靶点
Biomedicines. 2021 Jul 23;9(8):876. doi: 10.3390/biomedicines9080876.
培美曲塞联合西罗莫司治疗晚期既往治疗过的非小细胞肺癌的I/II期研究。
Transl Lung Cancer Res. 2019 Jun;8(3):247-257. doi: 10.21037/tlcr.2019.04.19.
4
Preparation of Ondansetron Hydrochloride-Loaded Nanostructured Lipid Carriers Using Solvent Injection Method for Enhancement of Pharmacokinetic Properties.盐酸昂丹司琼载药纳米结构脂质载体的溶剂注入法制备及其对药代动力学性质的改善。
Pharm Res. 2019 Jul 26;36(10):138. doi: 10.1007/s11095-019-2672-x.
5
Sirolimus and mTOR Inhibitors: A Review of Side Effects and Specific Management in Solid Organ Transplantation.西罗莫司和 mTOR 抑制剂:实体器官移植中不良反应及特定管理的综述。
Drug Saf. 2019 Jul;42(7):813-825. doi: 10.1007/s40264-019-00810-9.
6
Comparative preclinical evaluation of a polymer-free sirolimus-eluting stent in porcine coronary arteries.无聚合物西罗莫司洗脱支架在猪冠状动脉中的临床前比较评估。
Ther Adv Cardiovasc Dis. 2019 Jan-Dec;13:1753944719826335. doi: 10.1177/1753944719826335.
7
Efficacy and safety of low-dose Sirolimus in Lymphangioleiomyomatosis.西罗莫司治疗淋巴管肌瘤病的疗效和安全性。
Orphanet J Rare Dis. 2018 Nov 14;13(1):204. doi: 10.1186/s13023-018-0946-8.
8
Pharmacokinetic study of sirolimus ophthalmic formulations by consecutive sampling and liquid chromatography-tandem mass spectrometry.西罗莫司眼用制剂的药代动力学研究:连续采样和液相色谱-串联质谱法。
J Pharm Biomed Anal. 2019 Feb 5;164:337-344. doi: 10.1016/j.jpba.2018.10.051. Epub 2018 Oct 31.
9
Safety and efficacy of Rapamune® (Sirolimus) in kidney transplant recipients: results of a prospective post-marketing surveillance study in Korea.雷帕鸣(西罗莫司)在肾移植受者中的安全性和有效性:韩国一项上市后前瞻性监测研究的结果
BMC Nephrol. 2018 Aug 13;19(1):201. doi: 10.1186/s12882-018-1002-6.
10
Sirolimus for Secondary Prevention of Skin Cancer in Kidney Transplant Recipients: 5-Year Results.西罗莫司用于肾移植受者皮肤癌的二级预防:5 年结果。
J Clin Oncol. 2018 Sep 1;36(25):2612-2620. doi: 10.1200/JCO.2017.76.6691. Epub 2018 Jul 17.